Literature DB >> 15579522

Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals.

Linda Fried1, Cam Solomon, Michael Shlipak, Stephen Seliger, Catherine Stehman-Breen, Anthony J Bleyer, Paolo Chaves, Curt Furberg, Lewis Kuller, Anne Newman.   

Abstract

Inflammatory and prothrombotic markers are elevated in individuals with mild to moderate renal disease. It was hypothesized that these markers may also be determinants of the progression of renal disease. The association of six markers-serum C-reactive protein (CRP), white blood cell (WBC) count, fibrinogen, factor VII, albumin, and hemoglobin-with subsequent elevations of creatinine and decline in estimated GFR in the Cardiovascular Health Study, a community-based cohort of elderly individuals, was analyzed. Linear regression was used to determine predictors of an annualized change in serum creatinine as the main outcome. Duration of follow-up was 7 yr for the original cohort and 4 yr for the more recently recruited black cohort. A total of 588 (12.7%) individuals had a decline in estimated GFR of at least 3 ml/min per yr per 1.73 m(2). Higher CRP (P < 0.001), WBC count (P < 0.001), fibrinogen (P < 0.001), and factor VII (P < 0.001) levels and lower albumin (P < 0.001) and hemoglobin levels (P < 0.001) were associated with a rise in creatinine, after adjusting for age. With additional adjustments for race, gender, baseline creatinine, systolic and diastolic BP, lipid levels, weight, and pack-years smoking, higher CRP, factor VII, fibrinogen, WBC count, and lower albumin and hemoglobin levels remained associated with a rise in creatinine. Similar results were found for decline in estimated GFR. The decline in GFR was greater with increasing number of inflammatory or prothrombotic markers that were above the median (below for hemoglobin and albumin). Inflammatory and prothrombotic markers are predictors for a change in kidney function in elderly individuals. Interventions that reduce inflammation might confer significant cardiovascular and renal benefits.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15579522     DOI: 10.1097/01.ASN.0000146422.45434.35

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  84 in total

Review 1.  Proteomic biomarkers in kidney disease: issues in development and implementation.

Authors:  Harald Mischak; Christian Delles; Antonia Vlahou; Raymond Vanholder
Journal:  Nat Rev Nephrol       Date:  2015-02-03       Impact factor: 28.314

2.  Healthy Dietary Patterns and Incidence of CKD: A Meta-Analysis of Cohort Studies.

Authors:  Katrina E Bach; Jaimon T Kelly; Suetonia C Palmer; Saman Khalesi; Giovanni F M Strippoli; Katrina L Campbell
Journal:  Clin J Am Soc Nephrol       Date:  2019-09-24       Impact factor: 8.237

Review 3.  Statins, inflammation and kidney disease.

Authors:  Vera Krane; Christoph Wanner
Journal:  Nat Rev Nephrol       Date:  2011-05-31       Impact factor: 28.314

4.  Body mass index and annual estimated GFR decline in Chinese adults with normal renal function.

Authors:  Y Li; X Qin; D Xie; G Tang; H Xing; Z Li; X Xu; F Hou; X Xu
Journal:  Eur J Clin Nutr       Date:  2014-10-29       Impact factor: 4.016

5.  Atrial fibrillation and kidney disease: insights on a close relationship.

Authors:  Giorgio Trivioli
Journal:  Intern Emerg Med       Date:  2019-07-17       Impact factor: 3.397

6.  Hemostatic Factors, APOL1, and ESRD Risk: Another Piece of the Puzzle?

Authors:  Walter G Wasser; Etty Kruzel-Davila
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-17       Impact factor: 8.237

7.  C-reactive protein concentration as a predictor of in-hospital mortality after ICU discharge: a prospective cohort study.

Authors:  Kwok M Ho; Kok Y Lee; Geoffrey J Dobb; Steven A R Webb
Journal:  Intensive Care Med       Date:  2007-11-09       Impact factor: 17.440

8.  Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study.

Authors:  Michelle C Odden; Rebecca Scherzer; Peter Bacchetti; Lynda Anne Szczech; Stephen Sidney; Carl Grunfeld; Michael G Shlipak
Journal:  Arch Intern Med       Date:  2007-11-12

9.  CRP polymorphisms and progression of chronic kidney disease in African Americans.

Authors:  Adriana M Hung; Dana C Crawford; Marie R Griffin; Kristin Brown-Gentry; Michael S Lipkowitz; Edward D Siew; Kerri Cavanaugh; Julia B Lewis; T Alp Ikizler
Journal:  Clin J Am Soc Nephrol       Date:  2009-12-03       Impact factor: 8.237

10.  The relation of C--reactive protein to chronic kidney disease in African Americans: the Jackson Heart Study.

Authors:  Ervin R Fox; Emelia J Benjamin; Daniel F Sarpong; Harsha Nagarajarao; Jason K Taylor; Michael W Steffes; Abdullah K Salahudeen; Michael F Flessner; Ermeg L Akylbekova; Caroline S Fox; Robert J Garrison; Herman A Taylor
Journal:  BMC Nephrol       Date:  2010-01-15       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.